busulfan has been researched along with Injuries, Radiation in 27 studies
Excerpt | Relevance | Reference |
---|---|---|
"Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 6.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
"Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 2.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (59.26) | 18.7374 |
1990's | 5 (18.52) | 18.2507 |
2000's | 5 (18.52) | 29.6817 |
2010's | 1 (3.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wilhelmsson, M | 1 |
Vatanen, A | 1 |
Borgström, B | 2 |
Gustafsson, B | 1 |
Taskinen, M | 1 |
Saarinen-Pihkala, UM | 1 |
Winiarski, J | 1 |
Jahnukainen, K | 1 |
Shigematsu, A | 1 |
Yasumoto, A | 1 |
Yamamoto, S | 1 |
Sugita, J | 1 |
Kondo, T | 1 |
Onozawa, M | 1 |
Kahata, K | 1 |
Endo, T | 1 |
Ota, S | 1 |
Sato, N | 1 |
Takahata, M | 1 |
Okada, K | 1 |
Tanaka, J | 1 |
Hashino, S | 1 |
Nishio, M | 1 |
Koike, T | 1 |
Asaka, M | 1 |
Imamura, M | 1 |
Bölling, T | 1 |
Dirksen, U | 1 |
Ranft, A | 1 |
Ernst, I | 1 |
Jürgens, H | 1 |
Willich, N | 1 |
ASANO, M | 1 |
ODELL, TT | 1 |
McDONALD, TP | 1 |
UPTON, AC | 2 |
MAISIN, J | 1 |
DUNJIC, A | 1 |
CONKLIN, JW | 1 |
CHRISTENBERRY, KW | 1 |
VONSALLMANN, L | 1 |
Walther, J | 1 |
Sivabalasingham, S | 1 |
Plowman, PN | 1 |
Collis, CH | 1 |
Beschorner, WE | 1 |
Giorgiani, G | 1 |
Bozzola, M | 1 |
Locatelli, F | 1 |
Picco, P | 1 |
Zecca, M | 1 |
Cisternino, M | 1 |
Dallorso, S | 1 |
Bonetti, F | 1 |
Dini, G | 1 |
Borrone, C | 1 |
Domenech, J | 1 |
Linassier, C | 1 |
Gihana, E | 1 |
Dayan, A | 1 |
Truglio, D | 1 |
Bout, M | 1 |
Petitdidier, C | 1 |
Delain, M | 1 |
Petit, A | 1 |
Brémond, JL | 1 |
Vowels, M | 1 |
Chan, LL | 1 |
Giri, N | 1 |
Russell, S | 1 |
Lam-Po-Tang, R | 1 |
Wendt, TG | 1 |
Ringdén, O | 1 |
Remberger, M | 1 |
Ruutu, T | 1 |
Nikoskelainen, J | 1 |
Volin, L | 1 |
Vindeløv, L | 1 |
Parkkali, T | 1 |
Lenhoff, S | 1 |
Sallerfors, B | 1 |
Mellander, L | 1 |
Ljungman, P | 1 |
Jacobsen, N | 1 |
Holmström, G | 1 |
Calissendorff, B | 1 |
Ayas, M | 1 |
Belgaumi, A | 1 |
Al-Mahr, M | 1 |
Al-Jefri, A | 1 |
Solh, H | 1 |
Leung, W | 1 |
Lippmann, M | 1 |
Majewski, F | 1 |
Iurlo, A | 1 |
Foa, P | 1 |
Maiolo, AT | 1 |
Polli, EE | 1 |
Vassal, G | 1 |
Hartmann, O | 1 |
Habrand, JL | 1 |
Pico, JL | 1 |
Lemerle, J | 1 |
Levantine, A | 1 |
Almeyda, J | 1 |
Schwarz, MI | 1 |
Whitcomb, ME | 1 |
Goldman, AL | 1 |
Tange, T | 1 |
Finley, R | 1 |
Kieff, E | 1 |
Thomsen, S | 1 |
Fennessy, J | 1 |
Beem, M | 1 |
Lerner, S | 1 |
Morello, J | 1 |
Meschan, I | 1 |
Hines, WB | 1 |
Scharyj, M | 1 |
Tuchmann-Duplessis, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Chronic Phase CML[NCT00001144] | Phase 2 | 50 participants | Interventional | 1999-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for busulfan and Injuries, Radiation
Article | Year |
---|---|
Lung damage from cytotoxic drugs.
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carmustine; Chlorambucil; Cyclophosphamide | 1980 |
Destruction of the intestinal mucosa after bone marrow transplantation and graft-versus-host disease.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Chronic Disease; Combined Modality Therapy; Cy | 1984 |
Pulmonary reactions to drugs.
Topics: Adrenal Cortex Hormones; Aged; Aminoglycosides; Bleomycin; Busulfan; Contraceptives, Oral; Female; F | 1977 |
[On certain embryopathies induced by teratogenic agents (author's transl].
Topics: Abnormalities, Drug-Induced; Aminopterin; Busulfan; Chlorambucil; Cyclophosphamide; Ethanol; Germany | 1977 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor | 1974 |
The spectrum of diffuse pulmonary infiltration in malignant disease.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Busulfan; Embolism, Fat; Hemorrhage; Hodgkin Disease; Humans; I | 1973 |
1 trial available for busulfan and Injuries, Radiation
Article | Year |
---|---|
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta
Topics: Adolescent; Adult; Alopecia; Bone Marrow Transplantation; Bronchiolitis Obliterans; Busulfan; Catara | 1999 |
20 other studies available for busulfan and Injuries, Radiation
Article | Year |
---|---|
Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
Topics: Adolescent; Allografts; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Pres | 2014 |
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antigens, Viral; Bone Marrow Transplantation; Busulf | 2009 |
Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Chemotherapy, | 2009 |
Radiomimetic agents and x-rays in mice and AET protectiveness. Comparative pathological effects.
Topics: Animals; beta-Aminoethyl Isothiourea; Busulfan; Mechlorethamine; Mice; Protective Agents; Radiation | 1963 |
[THE POSSIBLE ROLE OF THE THYMUS AND OF LYMPHOID TISSUE IN SECONDARY DISEASE IN THE RAT].
Topics: Anemia; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Lymphoid Tissue; Pharmacology; Phys | 1963 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
CYTOLOGIC STUDIES ON LENS EPITHELIUM. A COMPARISON OF EFFECTS OF X-RAYS, MYLERAN, AND TEM.
Topics: Busulfan; Cell Division; Epithelium; Lens, Crystalline; Pharmacology; Radiation Injuries; Radiation | 1965 |
Chemotherapy and radiotherapy causing radiation myelopathy: what is to blame?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Humans; Male; | 2006 |
Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Height; Bone Marrow Transplantation; Busulfan; | 1995 |
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transpla | 1995 |
Factors affecting hair regrowth after bone marrow transplantation.
Topics: Adolescent; Adult; Age Factors; Alopecia; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan | 1993 |
[Late toxicity after allogeneic bone marrow transplantation in children in relation to conditioning regimen: whole body irradiation versus busulfan].
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body | 1998 |
Cataract in children after bone marrow transplantation: relation to conditioning regimen.
Topics: Bone Marrow Transplantation; Busulfan; Cataract; Cataract Extraction; Child; Child, Preschool; Femal | 2002 |
Allogeneic BMT for infantile acute leukemia: what is the optimal conditioning regimen?
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Etopo | 2002 |
Chronic myelogenous leukemia following radiation therapy for testicular seminoma.
Topics: Adult; Busulfan; Combined Modality Therapy; Dysgerminoma; Humans; Leukemia, Myelogenous, Chronic, BC | 1989 |
Radiosensitization after busulphan.
Topics: Busulfan; Child; Female; Humans; Radiation Injuries; Radiation-Sensitizing Agents; Skin | 1987 |
An experimental study on the significance of the bone marrow lymphocyte in haematopoietic regeneration following acute injury due to 60CO irradiation and cytotoxic drugs.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Busulfan; Cobalt Radioisotopes; Cytarabine; Hematopoietic S | 1974 |
Bronchial brushing in the diagnosis of pulmonary disease in patients at risk for opportunistic infection.
Topics: Aspergillosis; Bacterial Infections; Biopsy; Busulfan; Chickenpox; Coccidioidomycosis; Herpes Simple | 1974 |
Bronchopulmonary dysplasia--what is it?
Topics: Bronchial Diseases; Busulfan; Hodgkin Disease; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mi | 1973 |
[The teratogenic risk].
Topics: Abnormalities, Drug-Induced; Animals; Azathioprine; Busulfan; Carbutamide; Congenital Abnormalities; | 1968 |